SIGNATURERX Trademark

Trademark Overview

On Thursday, May 4, 2023, a trademark application was filed for SIGNATURERX with the United States Patent and Trademark Office. The USPTO has given the SIGNATURERX trademark a serial number of 97920185. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Thursday, October 10, 2024. This trademark is owned by PharmaPac Holdings. The SIGNATURERX trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Contract manufacturing in the field of pharmaceuticals
signaturerx

General Information

Serial Number97920185
Word MarkSIGNATURERX
Filing DateThursday, May 4, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateThursday, October 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesContract manufacturing in the field of pharmaceuticals
Pseudo MarkSIGNATURE

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, June 2, 2023
Primary Code040
First Use Anywhere DateWednesday, June 11, 2014
First Use In Commerce DateWednesday, June 11, 2014

Trademark Owner History

Party NamePharmaPac Holdings
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDelray Beach, FL 33444

Trademark Events

Event DateEvent Description
Monday, May 8, 2023NEW APPLICATION ENTERED
Friday, June 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 23, 2024ASSIGNED TO EXAMINER
Tuesday, June 25, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, June 25, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, June 25, 2024PETITION TO REVIVE-GRANTED
Tuesday, June 25, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 25, 2024NON-FINAL ACTION WRITTEN
Thursday, January 25, 2024NON-FINAL ACTION E-MAILED
Thursday, January 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 20, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, May 20, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, October 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 9, 2024ASSIGNED TO LIE
Thursday, October 10, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, October 10, 2024FINAL REFUSAL E-MAILED
Thursday, October 10, 2024FINAL REFUSAL WRITTEN

Related Keywords

signaturerx pharmaceuticals field manufacturing contract